142 related articles for article (PubMed ID: 36190971)
1. IDO1 Is a Therapeutic Target for Pancreatic Cancer-Associated Depression.
Hue JJ; Graor HJ; Zarei M; Katayama ES; Ji K; Hajihassani O; Loftus AW; Vaziri-Gohar A; Winter JM
Mol Cancer Ther; 2022 Dec; 21(12):1810-1822. PubMed ID: 36190971
[TBL] [Abstract][Full Text] [Related]
2. The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1.
Panfili E; Mondanelli G; Orabona C; Gargaro M; Volpi C; Belladonna ML; Rossini S; Suvieri C; Pallotta MT
Front Immunol; 2023; 14():1134551. PubMed ID: 37122718
[TBL] [Abstract][Full Text] [Related]
3. IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer.
Liang H; Li T; Fang X; Xing Z; Zhang S; Shi L; Li W; Guo L; Kuang C; Liu H; Yang Q
Cancer Lett; 2021 Dec; 522():32-43. PubMed ID: 34520819
[TBL] [Abstract][Full Text] [Related]
4. Target exposure and pharmacodynamics study of the indoleamine 2,3-dioxygenase-1 (IDO-1) inhibitor epacadostat in the CT26 mouse tumor model.
Poncelet L; Ait-Belkacem R; Marillier R; Gomes B; Stauber J
J Pharm Biomed Anal; 2019 Jun; 170():220-227. PubMed ID: 30933897
[TBL] [Abstract][Full Text] [Related]
5. Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy.
Xie W; Cai L; Yu Y; Gao L; Xiao L; He Q; Ren Z; Liu Y
J Neuroinflammation; 2014 Mar; 11():41. PubMed ID: 24594021
[TBL] [Abstract][Full Text] [Related]
6. Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells.
Rossini S; Ambrosino S; Volpi C; Belladonna ML; Pallotta MT; Panfili E; Suvieri C; Macchiarulo A; Mondanelli G; Orabona C
Front Immunol; 2024; 15():1346686. PubMed ID: 38333210
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
Kim M; Tomek P
Front Immunol; 2021; 12():636081. PubMed ID: 33708223
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors.
Xia Z; Nan Y; Liu C; Lin G; Gu K; Chen C; Zhao W; Ju D; Dong X
Anticancer Agents Med Chem; 2020; 20(13):1592-1603. PubMed ID: 32496990
[TBL] [Abstract][Full Text] [Related]
9. Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice.
Zhou W; Dantzer R; Budac DP; Walker AK; Mao-Ying QL; Lee AW; Heijnen CJ; Kavelaars A
Brain Behav Immun; 2015 May; 46():147-53. PubMed ID: 25637485
[TBL] [Abstract][Full Text] [Related]
10. Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase.
Fuertig R; Azzinnari D; Bergamini G; Cathomas F; Sigrist H; Seifritz E; Vavassori S; Luippold A; Hengerer B; Ceci A; Pryce CR
Brain Behav Immun; 2016 May; 54():59-72. PubMed ID: 26724575
[TBL] [Abstract][Full Text] [Related]
11. Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice.
Jackman KA; Brait VH; Wang Y; Maghzal GJ; Ball HJ; McKenzie G; De Silva TM; Stocker R; Sobey CG
Naunyn Schmiedebergs Arch Pharmacol; 2011 May; 383(5):471-81. PubMed ID: 21359968
[TBL] [Abstract][Full Text] [Related]
12. Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice.
Aslamkhan AG; Xu Q; Loughlin A; Vu H; Pacchione S; Bhatt B; Garfinkel I; Styring TG; LaFranco-Scheuch L; Pearson K; Reynolds S; Li N; Zhou H; Miller JR; Solban N; Bass A; Glaab WE
Toxicol Appl Pharmacol; 2020 Nov; 406():115216. PubMed ID: 32871117
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated.
Charehjoo A; Majidpoor J; Mortezaee K
Int Immunopharmacol; 2023 May; 118():110032. PubMed ID: 36933494
[TBL] [Abstract][Full Text] [Related]
14. Disruption of microglia histone acetylation and protein pathways in mice exhibiting inflammation-associated depression-like symptoms.
Rodriguez-Zas SL; Wu C; Southey BR; O'Connor JC; Nixon SE; Garcia R; Zavala C; Lawson M; McCusker RH; Romanova EV; Sweedler JV; Kelley KW; Dantzer R
Psychoneuroendocrinology; 2018 Nov; 97():47-58. PubMed ID: 30005281
[TBL] [Abstract][Full Text] [Related]
15. The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells.
Jochems C; Fantini M; Fernando RI; Kwilas AR; Donahue RN; Lepone LM; Grenga I; Kim YS; Brechbiel MW; Gulley JL; Madan RA; Heery CR; Hodge JW; Newton R; Schlom J; Tsang KY
Oncotarget; 2016 Jun; 7(25):37762-37772. PubMed ID: 27192116
[TBL] [Abstract][Full Text] [Related]
16. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan catabolism is dysregulated in leiomyomas.
Chuang TD; Quintanilla D; Boos D; Khorram O
Fertil Steril; 2021 Oct; 116(4):1160-1171. PubMed ID: 34116832
[TBL] [Abstract][Full Text] [Related]
18. Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation.
Imbeault S; Goiny M; Liu X; Erhardt S
Acta Neuropsychiatr; 2020 Feb; 32(1):43-53. PubMed ID: 31753057
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-Dioxygenase-Dependent Neurotoxic Kynurenine Metabolism Contributes to Poststroke Depression Induced in Mice by Ischemic Stroke along with Spatial Restraint Stress.
Koo YS; Kim H; Park JH; Kim MJ; Shin YI; Choi BT; Lee SY; Shin HK
Oxid Med Cell Longev; 2018; 2018():2413841. PubMed ID: 30693061
[TBL] [Abstract][Full Text] [Related]
20. Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells.
Newman AC; Falcone M; Huerta Uribe A; Zhang T; Athineos D; Pietzke M; Vazquez A; Blyth K; Maddocks ODK
Mol Cell; 2021 Jun; 81(11):2290-2302.e7. PubMed ID: 33831358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
